Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microsomal glutathione S-transferase 3 (MGST3) is a membrane-associated enzyme of the glutathione S-transferase superfamily, classified within the MAPEG family. It plays a central role in cellular detoxification by catalyzing the conjugation of reduced glutathione to reactive lipid peroxidation products and xenobiotic electrophiles, reducing oxidative cellular damage. MGST3 demonstrates both glutathione transferase and peroxidase activities, notably in the biosynthesis of leukotriene C4 and the reduction of lipid hydroperoxides. MGST3 is implicated in inflammation and neuroanatomical modulation, with genetic variability affecting susceptibility to neurodegenerative and inflammatory diseases. Its enzymatic activity is essential for regulating oxidative stress and maintaining neuronal health[1][3][4].
Drugs that inhibit or modulate MGST3 would alter cellular detoxification of electrophilic compounds and lipid peroxides, and may influence eicosanoid/inflammatory mediator biosynthesis. Agents targeting glutathione S-transferase activity could impact oxidative stress response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microsomal glutathione S-transferase 3 (MGST3).